-
The Concentrations of Some Gut Polypeptides Are Elevated During Lactation in Ruminants
Anne Faulkner and Pamela A Martin
Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology
(1997)
118 :563
-
Plasma concentrations and effects of glucagon-like peptide-1 (7-36) amide in calves before and after weaning
R. Fukumori, T. Mita, T. Sugino, T. Obitsu, and K. Taniguchi
Domestic Animal Endocrinology
(2012)
43 :299
-
Mixed meal ingestion diminishes glucose excursion in comparison with glucose ingestion via several adaptive mechanisms in
people with and without type 2 diabetes
W. Alsalim, A. Tura, G. Pacini, B. Omar, R. Bizzotto, A. Mari, and B. Ahrén
Diabetes, Obesity and Metabolism
(2016)
18 :24
-
The functional involvement of gut-expressed sweet taste receptors in glucose-stimulated secretion of glucagon-like peptide-1
(GLP-1) and peptide YY (PYY)
R.E. Steinert, A.C. Gerspach, H. Gutmann, L. Asarian, J. Drewe, and C. Beglinger
Clinical Nutrition
(2011)
30 :524
-
Glucagonlike peptide 1: A newly discovered gastrointestinal hormone
Jens Juul Holst
Gastroenterology
(1994)
107 :1848
-
Establishment of new clonal pancreatic β-cell lines (MIN6-K) useful for study of incretin/cyclic adenosine monophosphate signaling
Masahiro Iwasaki, Kohtaro Minami, Tadao Shibasaki, Takashi Miki, Jun-ichi Miyazaki, and Susumu Seino
Journal of Diabetes Investigation
(2010)
:no
-
Protein Digestion-Derived Peptides and the Peripheral Regulation of Food Intake
Juliette Caron, Dorothée Domenger, Pascal Dhulster, Rozenn Ravallec, and Benoit Cudennec
Frontiers in Endocrinology
(2017)
8 :
-
The gut endocrine system as a coordinator of postprandial nutrient homoeostasis
Fiona M. Gribble
Proceedings of the Nutrition Society
(2012)
71 :456
-
Targeting the glucagon receptor family for diabetes and obesity therapy
Young Min Cho, Catherine E. Merchant, and Timothy J. Kieffer
Pharmacology & Therapeutics
(2012)
135 :247
-
Glucose-dependent action of glucagon-like peptide-1(7-37) in vivo during short- or long-term administration
Diane M. Hargrove, Nancy A. Nardone, Lorna M. Persson, Janice C. Parker, and Ralph W. Stevenson
Metabolism
(1995)
44 :1231
-
Role of TCF7L2 risk variant and dietary fibre intake on incident type 2 diabetes
G. Hindy, E. Sonestedt, U. Ericson, X.-J. Jing, Y. Zhou, O. Hansson, E. Renström, E. Wirfält, and M. Orho-Melander
Diabetologia
(2012)
55 :2646
-
Glucagon-Like Peptide-1 Secreting Cell Function as well as Production of Inflammatory Reactive Oxygen Species Is Differently
Regulated by Glycated Serum and High Levels of Glucose
Alessandra Puddu, Roberta Sanguineti, Fabrizio Montecucco, and Giorgio L. Viviani
Mediators of Inflammation
(2014)
2014 :1
-
Role of glucagon-like peptide-1 in the pathogenesis and treatment of diabetes mellitus
Diva D. De León, Michael F. Crutchlow, Jee-Young Nina Ham, and Doris A. Stoffers
The International Journal of Biochemistry & Cell Biology
(2006)
38 :845
-
Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes
and non-alcoholic fatty liver disease
A. Zarrinpar and R. Loomba
Alimentary Pharmacology & Therapeutics
(2012)
36 :909
-
The major glucagon-like peptide-1 metabolite, GLP-1-(9–36)-amide, does not affect glucose or insulin levels in mice
Bidda Rolin, Carolyn F Deacon, Richard D Carr, and Bo Ahrén
European Journal of Pharmacology
(2004)
494 :283
-
Glucagon-like peptide-1 reduces contractile function and fails to boost glucose utilization in normal hearts in the presence
of fatty acids
T. Dung Nguyen, Yasushige Shingu, Paulo A. Amorim, Michael Schwarzer, and Torsten Doenst
International Journal of Cardiology
(2013)
168 :4085
-
GIP and GLP-1(7–36)amide secretion in response to intraduodenal infusions of nutrients in pigs
J.M.E. Knapper, A. Heath, J.M. Fletcher, L.M. Morgan, and V. Marks
Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology
(1995)
111 :445
-
Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans
Qiang Xiao, Robin P. Boushey, Daniel J. Drucker, and Patricia L. Brubaker
Gastroenterology
(1999)
117 :99
-
Nutrient detection by incretin hormone secreting cells
Eleftheria Diakogiannaki, Fiona M. Gribble, and Frank Reimann
Physiology & Behavior
(2012)
106 :387
-
Dietary sweet potato (Ipomoea batatas L.) leaf extract attenuates hyperglycaemia by enhancing the secretion of glucagon-like
peptide-1 (GLP-1)
Rika Nagamine, Shiori Ueno, Masahito Tsubata, Kazuya Yamaguchi, Kinya Takagaki, Tohru Hira, Hiroshi Hara, and Takanori Tsuda
Food & Function
(2014)
5 :2309
-
Alternative form of glucose-dependent insulinotropic polypepide and its physiology
Yukihiro Fujita, Tsuyoshi Yanagimachi, Yasutaka Takeda, Jun Honjo, Yumi Takiyama, Atsuko Abiko, Yuichi Makino, and Masakazu
Haneda
Journal of Diabetes Investigation
(2016)
7 :33
-
Possible role of PEPT1 in gastrointestinal hormone secretion
Kimio Matsumura, Takashi Miki, Takahito Jhomori, Tohru Gonoi, and Susumu Seino
Biochemical and Biophysical Research Communications
(2005)
336 :1028
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of BI 1356, an Inhibitor of Dipeptidyl Peptidase
4, in Healthy Male Volunteers
S. Hüttner, E. U. Graefe-Mody, B. Withopf, A. Ring, and K. A. Dugi
The Journal of Clinical Pharmacology
(2008)
48 :1171
-
Insulin modulates glucose-dependent insulinotropic polypeptide (GIP) secretion from enteroendocrine K cells in rats
Nigel Irwin, Jacqueline M.E. Francis, and Peter R. Flatt
Biological Chemistry
(2011)
392 :
-
Gut?Brain Axis: Regulation of Glucose Metabolism
A. C. Heijboer, H. Pijl, A. M. Van den Hoek, L. M. Havekes, J. A. Romijn, and E. P. M. Corssmit
Journal of Neuroendocrinology
(2006)
18 :883
-
The effect of circulating non-esterified fatty acids on the entero-insular axis
Ranganath, Norris, Morgan, Wright, and Marks
European Journal of Clinical Investigation
(1999)
29 :27
-
Plant-rich mixed meals based on Palaeolithic diet principles have a dramatic impact on incretin, peptide YY and satiety response,
but show little effect on glucose and insulin homeostasis: an acute-effects randomised study
H. Frances J. Bligh, Ian F. Godsland, Gary Frost, Karl J. Hunter, Peter Murray, Katrina MacAulay, Della Hyliands, Duncan C.
S. Talbot, John Casey, Theo P. J. Mulder, and Mark J. Berry
British Journal of Nutrition
(2015)
113 :574
-
Energy expenditure by intravenous administration of glucagon-like peptide-1 mediated by the lower brainstem and sympathoadrenal
system
Toshimasa Osaka, Mari Endo, Midori Yamakawa, and Shuji Inoue
Peptides
(2005)
26 :1623
-
Dietary supplementation with hydroxypropyl-distarch phosphate from waxy maize starch increases resting energy expenditure
by lowering the postprandial glucose-dependent insulinotropic polypeptide response in human subjects
Akira Shimotoyodome, Junko Suzuki, Yoji Kameo, and Tadashi Hase
British Journal of Nutrition
(2011)
106 :96
-
Raised FGF-21 and Triglycerides Accompany Increased Energy Intake Driven by Protein Leverage in Lean, Healthy Individuals:
A Randomised Trial
Alison K. Gosby, Namson S. Lau, Charmaine S. Tam, Miguel A. Iglesias, Christopher D. Morrison, Ian D. Caterson, Jennie Brand-Miller,
Arthur D. Conigrave, David Raubenheimer, Stephen J. Simpson, and Darcy Johannsen
PLOS ONE
(2016)
11 :e0161003
-
Pharmacokinetics and Pharmacodynamics of Vildagliptin??in??Patients?? with Type??2??Diabetes??Mellitus
Yan-Ling He, Denise Serra, Yibin Wang, Joelle Campestrini, Gilles-Jacques Riviere, Carolyn F Deacon, Jens J Holst, Sherwyn
Schwartz, Jace C Nielsen, and Monica Ligueros-Saylan
Clinical Pharmacokinetics
(2007)
46 :577
-
Circadian Aspects of Postprandial Metabolism
Linda Morgan, Shelagh Hampton, Michelle Gibbs, and Josephine Arendt
Chronobiology International
(2003)
20 :795
-
Harnessing the gut to treat diabetes
Yukihiro Fujita, Anthony T. Cheung, and Timothy J. Kieffer
Pediatric Diabetes
(2004)
5 :57
-
Combination treatment with alogliptin and voglibose increases active GLP-1 circulation, prevents the development of diabetes
and preserves pancreatic beta-cells in prediabeticdb/dbmice
Y. Moritoh, K. Takeuchi, and M. Hazama
Diabetes, Obesity and Metabolism
(2010)
12 :224
-
Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness
Dominique Delmeire, Daisy Flamez, Karen Moens, Simon A Hinke, Chris Van Schravendijk, Daniel Pipeleers, and Frans Schuit
Biochemical Pharmacology
(2004)
68 :33
-
Beneficial metabolic actions of a stable GIP agonist following pre-treatment with a SGLT2 inhibitor in high fat fed diabetic
mice
P.J.B. Millar, V. Pathak, R.C. Moffett, N.M. Pathak, A.J. Bjourson, M.J. O'Kane, P.R. Flatt, and V.A. Gault
Molecular and Cellular Endocrinology
(2016)
420 :37
-
Circadian Secretion of the Intestinal Hormone GLP-1 by the Rodent L Cell
Manuel Gil-Lozano, Erli L. Mingomataj, W. Kelly Wu, Sean A. Ridout, and Patricia L. Brubaker
Diabetes
(2014)
63 :3674
-
Mechanisms for the cardiovascular effects of glucagon-like peptide-1
H. Poudyal
Acta Physiologica
(2016)
216 :277
-
Incretin actions and consequences of incretin-based therapies: lessons from complementary animal models
Simone Renner, Andreas Blutke, Elisabeth Streckel, Rüdiger Wanke, and Eckhard Wolf
The Journal of Pathology
(2016)
238 :345
-
Molecular Mechanisms of Glucose-Stimulated GLP-1 Secretion From Perfused Rat Small Intestine
Rune E. Kuhre, Charlotte R. Frost, Berit Svendsen, and Jens J. Holst
Diabetes
(2015)
64 :370
-
Nutritional sensing and its utility in treating obesity
Anjali Amin and Kevin G Murphy
Expert Review of Endocrinology & Metabolism
(2012)
7 :209
-
A Tripeptide Diapin Effectively Lowers Blood Glucose Levels in Male Type 2 Diabetes Mice by Increasing Blood Levels of Insulin
and GLP-1
Jifeng Zhang, Changyong Xue, Tianqing Zhu, Anuradha Vivekanandan, Subramaniam Pennathur, Zhongmin Alex Ma, Y. Eugene Chen,
and Tianru Jin
PLoS ONE
(2013)
8 :e83509
-
On the Effects of Glucagon-Like Peptide-1 on Blood Glucose Regulation in Normal and Diabetic Subjects
JENS JUUL HOLST, MAJ-BRIT TOFT-NIELSEN, CATHRINE ØRSKOV, MICHAEL NAUCK, and BEHREND WILLMS
Annals of the New York Academy of Sciences
(2006)
805 :729
-
G-Protein-Coupled Receptors in Intestinal Chemosensation
Frank Reimann, Gwen Tolhurst, and Fiona M. Gribble
Cell Metabolism
(2012)
15 :421
-
DPP-4 inhibitors in the treatment of type 2 diabetes
Hélène Duez, Bertrand Cariou, and Bart Staels
Biochemical Pharmacology
(2012)
83 :823
-
Peripheral Glucagon-like Peptide-1 (GLP-1) and Satiation
Mukesh Punjabi, Myrtha Arnold, Nori Geary, Wolfgang Langhans, and Gustavo Pacheco-López
Physiology & Behavior
(2011)
105 :71
-
Once-weekly dulaglutide 1.5 mg restores insulin secretion in response to intravenous glucose infusion
Amparo de la Peña, Corina Loghin, Xuewei Cui, Xin Zhang, Christoph Kapitza, and Ronan P. Kelly
Diabetes, Obesity and Metabolism
(2017)
19 :517
-
Intestinal feedback signaling and satiety
Timothy H. Moran and Megan J. Dailey
Physiology & Behavior
(2011)
105 :77
-
Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes
Ann Mosegaard Bak, Lærke Egefjord, Michael Gejl, Charlotte Steffensen, Chalotte Willemann Stecher, Kamille Smidt, Birgitte
Brock, and Jørgen Rungby
Expert Opinion on Therapeutic Targets
(2011)
15 :1153
-
The hepatic vagal nerve is receptive to incretin hormone glucagon-like peptide-l, but not to glucose-dependent insulinotropic
polypeptide, in the portal vein
Makoto Nishizawa, Hajime Nakabayashi, Kenzo Uchida, Atsushi Nakagaw, and Akira Niijima
Journal of the Autonomic Nervous System
(1996)
61 :149
-
Ectopic expression of glucagon-like peptide 1 for gene therapy of type II diabetes
G B Parsons, D W Souza, H Wu, D Yu, S G Wadsworth, R J Gregory, and D Armentano
Gene Therapy
(2007)
14 :38
-
Ingestion of a moderate high-sucrose diet results in glucose intolerance with reduced liver glucokinase activity and impaired
glucagon-like peptide-1 secretion
Eriko Sakamoto, Yusuke Seino, Ayako Fukami, Naohiro Mizutani, Shin Tsunekawa, Kota Ishikawa, Hidetada Ogata, Eita Uenishi,
Hideki Kamiya, Yoji Hamada, Hiroyuki Sato, Norio Harada, Yukiyasu Toyoda, Ichitomo Miwa, Jiro Nakamura, Nobuya Inagaki, Yutaka
Oiso, and Nobuaki Ozaki
Journal of Diabetes Investigation
(2012)
3 :432
-
The effect of a high-MUFA, low-glycaemic index diet and a low-fat diet on appetite and glucose metabolism during a 6-month
weight maintenance period
Birgitte Sloth, Anette Due, Thomas M. Larsen, Jens J. Holst, Anders Heding, and Arne Astrup
British Journal of Nutrition
(2009)
101 :1846
-
Glucagon-like peptide-1 release and satiety after a nutrient challenge in normal-weight and obese subjects
Tanja C. M. Adam and Margriet S. Westerterp-Plantenga
British Journal of Nutrition
(2005)
93 :845
-
Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1
Jens Juul Holst
Diabetes/Metabolism Research and Reviews
(2002)
18 :430
-
Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells
H. E. Parker, A. M. Habib, G. J. Rogers, F. M. Gribble, and F. Reimann
Diabetologia
(2009)
52 :289
-
The entero-insular axis: implications for human metabolism
Lakshminarayan R. Ranganath
Clinical Chemistry and Laboratory Medicine
(2008)
46 :
-
The use of glycaemic index tables to predict glycaemic index of composite breakfast meals
Anne Flint, Bente K. Møller, Anne Raben, Dorthe Pedersen, Inge Tetens, Jens J. Holst, and Arne Astrup
British Journal of Nutrition
(2004)
91 :979
-
The effects of two different hypocaloric diets on glucagon-like peptide 1 in obese adults, relation with insulin response
after weight loss
Daniel A. de Luis, Manuel Gonzalez Sagrado, Rosa Conde, Rocio Aller, and Olatz Izaola
Journal of Diabetes and its Complications
(2009)
23 :239
-
Gastric emptying of glucose solution and associated plasma concentrations of GLP-1, GIP, and PYY before and after fundoplication
J. Miholic, M. Hoffmann, J.J. Holst, J. Lenglinger, M. Mittlböck, H. Bergmann, and G. Stacher
Surgical Endoscopy
(2007)
21 :309
-
Development of genetically engineered human intestinal cells for regulated insulin secretion using rAAV-mediated gene transfer
Shiue-Cheng Tang and Athanassios Sambanis
Biochemical and Biophysical Research Communications
(2003)
303 :645
-
Glucagon-Like Peptide 1 Secretion by the L-Cell: The View From Within
G. E. Lim and P. L. Brubaker
Diabetes
(2006)
55 :S70
-
GIP or not GIP? That is the question
Timothy J Kieffer
Trends in Pharmacological Sciences
(2003)
24 :110
-
Chlorogenic acid differentially affects postprandial glucose and glucose-dependent insulinotropic polypeptide response in
rats
Jasmine M. Tunnicliffe, Lindsay K. Eller, Raylene A. Reimer, Dustin S. Hittel, and Jane Shearer
Applied Physiology, Nutrition, and Metabolism
(2011)
36 :650
-
Classification and functions of enteroendocrine cells of the lower gastrointestinal tract
Ashok R. Gunawardene, Bernard M. Corfe, and Carolyn A. Staton
International Journal of Experimental Pathology
(2011)
92 :219
-
A Direct in Vivo Comparison of the Melanocortin Monovalent Agonist Ac-His-DPhe-Arg-Trp-NH2 versus the Bivalent Agonist Ac-His-DPhe-Arg-Trp-PEDG20-His-DPhe-Arg-Trp-NH2:
A Bivalent Advantage
Cody J. Lensing, Danielle N. Adank, Stacey L. Wilber, Katie T. Freeman, Sathya M. Schnell, Robert C. Speth, Adam T. Zarth,
and Carrie Haskell-Luevano
ACS Chemical Neuroscience
(2017)
:
-
Effects of glucagon-like peptide-1 and feeding on gastric volumes in diabetes mellitus with cardio-vagal dysfunction
S. Delgado-Aros, A. Vella, M. Camilleri, P. A. Low, D. D. Burton, G. M. Thomforde, and D. Stephens
Neurogastroenterology and Motility
(2003)
15 :435
-
Protein digestion and energy homeostasis: How generated peptides may impact intestinal hormones?
Juliette Caron, Dorothée Domenger, Yanath Belguesmia, Mostafa Kouach, Jean Lesage, Jean-François Goossens, Pascal Dhulster,
Rozenn Ravallec, and Benoit Cudennec
Food Research International
(2016)
88 :310
-
Glucagon-like Peptide 1 (GLP-1): An Intestinal Hormone, Signalling Nutritional Abundance, with an Unusual Therapeutic Potential
Jens Juul Holst
Trends in Endocrinology & Metabolism
(1999)
10 :229
-
Vesicular storage and secretion of l-glutamate from glucagon-like peptide 1-secreting clonal intestinal L cells
Shunsuke Uehara, Sun-Kyung Jung, Riyo Morimoto, Shigeo Arioka, Takaaki Miyaji, Narinobu Juge, Miki Hiasa, Kahori Shimizu,
Akinori Ishimura, Masato Otsuka, Akitsugu Yamamoto, Pierre Maechler, and Yoshinori Moriyama
Journal of Neurochemistry
(2006)
96 :550
-
Biology of Incretins: GLP-1 and GIP
Laurie L. Baggio and Daniel J. Drucker
Gastroenterology
(2007)
132 :2131
-
Glucagon-Like Peptide-1 Receptor Agonist Administration Suppresses Both Water and Saline Intake in Rats
N. J. McKay and D. Daniels
Journal of Neuroendocrinology
(2013)
25 :929
-
Absorption of glucagon-like peptide-1 can be protracted by zinc or protamine
Lone Pridal, Hanne Agerbæk, Lone N. Christensen, Karina Thomsen, and Ole Kirk
International Journal of Pharmaceutics
(1996)
136 :53
-
Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite
W. L. Hall, D. J. Millward, S. J. Long, and L. M. Morgan
British Journal of Nutrition
(2003)
89 :239
-
Physiology and Emerging Biochemistry of the Glucagon-Like Peptide-1 Receptor
Francis S. Willard and Kyle W. Sloop
Experimental Diabetes Research
(2012)
2012 :1
-
Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass
Ding Xie, Qing Zhong, Ke-Hong Ding, Hua Cheng, Sandra Williams, Daniel Correa, Wendy B. Bollag, Roni J. Bollag, Karl Insogna,
Nancy Troiano, Chistiane Coady, Mark Hamrick, and Carlos M. Isales
Bone
(2007)
40 :1352
-
Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis
S.T. Ngo, F.J. Steyn, L. Huang, S. Mantovani, C.M.M. Pfluger, T.M. Woodruff, J.D. O'Sullivan, R.D. Henderson, and P.A. McCombe
Journal of the Neurological Sciences
(2015)
357 :22
-
Glucose-Sensing in Glucagon-Like Peptide-1-Secreting Cells
F. Reimann and F. M. Gribble
Diabetes
(2002)
51 :2757
-
Identification and functional characterization of melatonin Mel 1a receptors in pancreatic β cells: potential role in incretin-mediated
cell function by sensitization of cAMP signaling
Daniel M Kemp, Mariano Ubeda, and Joel F Habener
Molecular and Cellular Endocrinology
(2002)
191 :157
-
Regulation of energy balance by a gut–brain axis and involvement of the gut microbiota
Paige V. Bauer, Sophie C. Hamr, and Frank A. Duca
Cellular and Molecular Life Sciences
(2016)
73 :737
-
Comparison of sandwich enzyme-linked immunoadsorbent assay and radioimmunoassay for determination of exogenous glucagon-like
peptide-1(7–36)amide in plasma
Lone Pridal, Steen H. Ingwersen, Flemming S. Larsen, Jens J. Holst, Kim Adelhorst, and Ole Kirk
Journal of Pharmaceutical and Biomedical Analysis
(1995)
13 :841
-
Galanin is a potent inhibitor of glucagon-like peptide-1 secretion from rat ileum
Christine Herrmann-Rinke, Dieter Hörsch, Gerard P. McGregor, and Burkhard Göke
Peptides
(1996)
17 :571
-
Proximate and Chemical Analysis of Gluten-free Enriched, Resistant Starch Type 3 from Maranta arundinacea Flour and its Potential
as a Functional Food
Mutiara Nugraheni, Badraningsih Lastariwat, and Sutriyati Purwanti
Pakistan Journal of Nutrition
(2017)
16 :322
-
The Melanocortin-4 Receptor Is Expressed in Enteroendocrine L Cells and Regulates the Release of Peptide YY and Glucagon-like
Peptide 1 In Vivo
Brandon L. Panaro, Iain R. Tough, Maja S. Engelstoft, Robert T. Matthews, Gregory J. Digby, Cathrine L. Møller, Berit Svendsen,
Fiona Gribble, Frank Reimann, Jens J. Holst, Birgitte Holst, Thue W. Schwartz, Helen M. Cox, and Roger D. Cone
Cell Metabolism
(2014)
20 :1018
-
Beta Glucan: Health Benefits in Obesity and Metabolic Syndrome
D. El Khoury, C. Cuda, B. L. Luhovyy, and G. H. Anderson
Journal of Nutrition and Metabolism
(2012)
2012 :1
-
Gastro-intestinal hormones GIP and GLP-1
T.J. Kieffer
Annales d'Endocrinologie
(2004)
65 :13
-
Intestinal GLP-1 and satiation—from man to rodents and back
R E Steinert, C Beglinger, and W Langhans
International Journal of Obesity
(2015)
:
-
Effects of Selenium and Exendin-4 on Glucagon-Like Peptide-1 Receptor, IRS-1, and Raf-1 in the Liver of Diabetic Rats
Ghinwa M. Barakat, Mohamed E. Moustafa, and Anwar B. Bikhazi
Biochemical Genetics
(2012)
50 :922
-
GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a
randomised trial
Özlem Gögebakan, Martin A. Osterhoff, Rita Schüler, Olga Pivovarova, Michael Kruse, Anne-Cathrin Seltmann, Alexander S. Mosig,
Natalia Rudovich, Michael Nauck, and Andreas F. H. Pfeiffer
Diabetologia
(2015)
58 :1759
-
Pancreatic β-cell signaling: toward better understanding of diabetes and its treatment
Susumu SEINO, Tadao SHIBASAKI, and Kohtaro MINAMI
Proceedings of the Japan Academy, Series B
(2010)
86 :563
-
Gut peptides in the treatment of diabetes mellitus
Torsten P Vahl and David A D’Alessio
Expert Opinion on Investigational Drugs
(2004)
13 :177
-
Oral delivery of therapeutic protein/peptide for diabetes – Future perspectives
M.R. Rekha and Chandra P. Sharma
International Journal of Pharmaceutics
(2013)
440 :48
-
Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects
M. D. Robertson, J. M. Currie, L. M. Morgan, D. P. Jewell, and K. N. Frayn
Diabetologia
(2003)
46 :659
-
Pharmacokinetics and Pharmacodynamics of Single Rising Intravenous Doses (0.5 mg–10 mg) and Determination of Absolute Bioavailability
of the Dipeptidyl Peptidase-4 Inhibitor Linagliptin (BI 1356) in Healthy Male Subjects
Silke Retlich, Vincent Duval, Arne Ring, Alexander Staab, Silke Hüttner, Arvid Jungnik, Ulrich Jaehde, Klaus A. Dugi, and
Ulrike Graefe-Mody
Clinical Pharmacokinetics
(2010)
49 :829
-
Sympathetic pathways mediate GLP-1 actions in the gastrointestinal tract of the rat
M. Giralt and P. Vergara
Regulatory Peptides
(1998)
74 :19
-
Lipids, CHOs, proteins: Can all macronutrients put a ‘brake’ on eating?
H.S. Shin, J.R. Ingram, A.-T. McGill, and S.D. Poppitt
Physiology & Behavior
(2013)
120 :114
-
Physiological mechanisms mediating aspartame-induced satiety
W.L. Hall, D.J. Millward, P.J. Rogers, and L.M. Morgan
Physiology & Behavior
(2003)
78 :557
-
A Radioimmunoassay for LY315902 an analog of Glucagon-like Insulinotropic Peptide, and Its Application in the Study of Canine
Pharmacokinetics
James Z. Chou, Gary D. Place, David G. Waters, Jeffrey A. Kirkwood, and Ronald R. Bowsher
Journal of Pharmaceutical Sciences
(1997)
86 :768
-
El GLP-1: acción biológica y posibles efectos terapéuticos
I. Valverde, J. Cancelas, and M.L. Villanueva-Peñacarrillo
Endocrinología y Nutrición
(2006)
53 :256
-
Effects of GLP-1 on appetite and weight
Meera Shah and Adrian Vella
Reviews in Endocrine and Metabolic Disorders
(2014)
15 :181
-
Effects of centrally-injected glucagon-like peptide-1 on pilocarpine-induced seizures, anxiety and locomotor and exploratory
activity in rat
Guldal Gulec, Naciye Isbil-Buyukcoskun, and Nevzat Kahveci
Neuropeptides
(2010)
44 :285
-
Gut chemosensing mechanisms
Arianna Psichas, Frank Reimann, and Fiona M. Gribble
Journal of Clinical Investigation
(2015)
125 :908
-
Nutrient sensing in the gut: interactions between chemosensory cells, visceral afferents and the secretion of satiation peptides
Robert E. Steinert and Christoph Beglinger
Physiology & Behavior
(2011)
105 :62
-
Different proteins and biopeptides differently affect satiety and anorexigenic/orexigenic hormones in healthy humans
K Diepvens, D Häberer, and M Westerterp-Plantenga
International Journal of Obesity
(2008)
32 :510
-
Gastrointestinal peptides after bariatric surgery and appetite control: are they in tuning?
Éric Doucet
Current Opinion in Clinical Nutrition and Metabolic Care
(2008)
11 :645
-
Phosphorus ingestion improves oral glucose tolerance of healthy male subjects: a crossover experiment
May Khattab, Christelle Abi-Rashed, Hala Ghattas, Sani Hlais, and Omar Obeid
Nutrition Journal
(2015)
14 :
-
GPR40 (FFAR1) – Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo
Maria Hauge, Marie A. Vestmar, Anna S. Husted, Jeppe P. Ekberg, Michael J. Wright, Jerry Di Salvo, Adam B. Weinglass, Maja
S. Engelstoft, Andreas N. Madsen, Michael Lückmann, Michael W. Miller, Maria E. Trujillo, Thomas M. Frimurer, Birgitte Holst,
Andrew D. Howard, and Thue W. Schwartz
Molecular Metabolism
(2015)
4 :3
-
Clinical Pharmacokinetics and Pharmacodynamics of Vildagliptin
Yan-Ling He
Clinical Pharmacokinetics
(2012)
51 :147
-
Role of Gastrointestinal Hormones in Postprandial Reduction of Bone Resorption
Dennis B Henriksen, Peter Alexandersen, Nina H Bjarnason, Tina Vilsbøll, Bolette Hartmann, Eva EG Henriksen, Inger Byrjalsen,
Thure Krarup, Jens J Holst, and Claus Christiansen
Journal of Bone and Mineral Research
(2003)
18 :2180
-
Distinct Effects of Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 on Insulin Secretion and Gut
Motility
T. Miki, K. Minami, H. Shinozaki, K. Matsumura, A. Saraya, H. Ikeda, Y. Yamada, J. J. Holst, and S. Seino
Diabetes
(2005)
54 :1056
-
The Effect of Extruded Orange Pulp on Enzymatic Hydrolysis of Starch and Glucose Retardation Index
Miguel Angel Larrea Céspedes, Fernando Martínez Bustos, and Yoon Kil chang
Food and Bioprocess Technology
(2010)
3 :684
-
Efficient GLP-1 gene delivery using two-step transcription amplification plasmid system with a secretion signal peptide and
arginine-grafted bioreducible polymer
Tae-il Kim, Minhyung Lee, and Sung Wan Kim
Journal of Controlled Release
(2012)
157 :243
-
Ability of GLP-1 to decrease food intake is dependent on nutritional status
Charlotte C. Ronveaux, Guillaume de Lartigue, and Helen E. Raybould
Physiology & Behavior
(2014)
135 :222
-
GPR119 Is Essential for Oleoylethanolamide-Induced Glucagon-Like Peptide-1 Secretion From the Intestinal Enteroendocrine L-Cell
L. M. Lauffer, R. Iakoubov, and P. L. Brubaker
Diabetes
(2009)
58 :1058
-
Possible role for apple juice phenolic compounds in the acute modification of glucose tolerance and gastrointestinal hormone
secretion in humans
Kelly L Johnston, Michael N Clifford, and Linda M Morgan
Journal of the Science of Food and Agriculture
(2002)
82 :1800
-
DPP4 inhibitors: from sitagliptin monotherapy to the new alogliptin-pioglitazone combination therapy
Georgia Argyrakopoulou and John Doupis
Advances in Therapy
(2009)
26 :272
-
The environment within: how gut microbiota may influence metabolism and body composition
A. Vrieze, F. Holleman, E. G. Zoetendal, W. M. de Vos, J. B. L. Hoekstra, and M. Nieuwdorp
Diabetologia
(2010)
53 :606
-
Secretion of the Incretin Hormones Glucagon-Like Peptide-1 and Gastric Inhibitory Polypeptide Correlates with Insulin Secretion
in Normal Man Throughout the Day
C. Ørskov, A. Wettergren, and J. J. Holst
Scandinavian Journal of Gastroenterology
(1996)
31 :665
-
Glucose-dependent insulinotropic polypeptide (GIP): anti-diabetic and anti-obesity potential?
Victor A. Gault, Finbarr P.M. O’Harte, and Peter R. Flatt
Neuropeptides
(2003)
37 :253
-
Pancreatic regulation of glucose homeostasis
Pia V Röder, Bingbing Wu, Yixian Liu, and Weiping Han
Experimental & Molecular Medicine
(2016)
48 :e219
-
Development of a cysteine-deprived and C-terminally truncated GLP-1 receptor
Christina Rye Underwood, Lotte Bjerre Knudsen, Patrick W. Garibay, Günther H. Peters, and Steffen Reedtz-Runge
Peptides
(2013)
49 :100
-
Novel N-substituted-2-cyanopyrrolidines as potent inhibitors of dipeptidyl peptidase IV in the treatment of non-insulin-dependent
diabetes mellitus
Expert Opinion on Therapeutic Patents
(2000)
10 :1937
-
GLP-1 and peptide YY secretory response after fat load is impaired by insulin resistance, impaired fasting glucose and type
2 diabetes in morbidly obese subjects
José C. Fernández-García, Mora Murri, Leticia Coin-Aragüez, Juan Alcaide, Rajaa El Bekay, and Francisco J. Tinahones
Clinical Endocrinology
(2014)
80 :671
-
Effect of GIP, GLP-1, insulin and gastrin on ghrelin release in the isolated rat stomach
Florian Lippl, Florian Kircher, Johannes Erdmann, Hans-Dieter Allescher, and Volker Schusdziarra
Regulatory Peptides
(2004)
119 :93
-
Imaging exocytosis of single glucagon-like peptide-1 containing granules in a murine enteroendocrine cell line with total
internal reflection fluorescent microscopy
Mica Ohara-Imaizumi, Kyota Aoyagi, Yoshihiro Akimoto, Yoko Nakamichi, Chiyono Nishiwaki, Hayato Kawakami, and Shinya Nagamatsu
Biochemical and Biophysical Research Communications
(2009)
390 :16
-
Expression of Na+/glucose co-transporter 1 (SGLT1) is enhanced by supplementation of the diet of weaning piglets with artificial
sweeteners
Andrew W. Moran, Miran A. Al-Rammahi, Daleep K. Arora, Daniel J. Batchelor, Erin A. Coulter, Kristian Daly, Catherine Ionescu,
David Bravo, and Soraya P. Shirazi-Beechey
British Journal of Nutrition
(2010)
104 :637
-
Oral Delivery of Glucagon Like Peptide-1 by a Recombinant Lactococcus lactis
Payal Agarwal, Pulkit Khatri, Blasé Billack, Woon-Kai Low, and Jun Shao
Pharmaceutical Research
(2014)
31 :3404
-
New treatments for type 2 diabetes mellitus: combined therapy with sitagliptin
Juan José Gagliardino, Silvina Santoro, Sara Arellano, and Guillermo Di Girolamo
Expert Opinion on Pharmacotherapy
(2008)
9 :1495
-
Effect of glucagon on carbohydrate-mediated secretion of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like
peptide-1 (7-36 amide) (GLP-1)
L. Ranganath, F. Schaper, R. Gama, L. Morgan, J. Wright, D. Teale, and V. Marks
Diabetes/Metabolism Research and Reviews
(1999)
15 :390
-
Role of Leptin in the Regulation of Glucagon-Like Peptide-1 Secretion
Y. Anini and P. L. Brubaker
Diabetes
(2003)
52 :252
-
Matching Meals to Body Clocks—Impact on Weight and Glucose Metabolism
Amy Hutchison, Gary Wittert, and Leonie Heilbronn
Nutrients
(2017)
9 :222
-
Liraglutide counteracts obesity and glucose intolerance in a mouse model of glucocorticoid-induced metabolic syndrome
Liselotte Fransson, Cristiane dos Santos, Petra Wolbert, Åke Sjöholm, Alex Rafacho, and Henrik Ortsäter
Diabetology & Metabolic Syndrome
(2014)
6 :3
-
Control of Food Intake by Gastrointestinal Peptides: Mechanisms of Action and Possible Modulation in the Treatment of Obesity
Philip Prinz and Andreas Stengel
Journal of Neurogastroenterology and Motility
(2017)
23 :180
-
A randomized, double-blind, placebo-controlled, multiple-dose, parallel-group clinical trial to assess the effects of teduglutide
on gastric emptying of liquids in healthy subjects
Jolene Kay Berg, Eric H Kim, Benjamin Li, Bo Joelsson, and Nader N Youssef
BMC Gastroenterology
(2014)
14 :
-
Glucose intolerance caused by a defect in the entero-insular axis: A study in gastric inhibitory polypeptide receptor knockout
mice
K. Miyawaki, Y. Yamada, H. Yano, H. Niwa, N. Ban, Y. Ihara, A. Kubota, S. Fujimoto, M. Kajikawa, A. Kuroe, K. Tsuda, H. Hashimoto,
T. Yamashita, T. Jomori, F. Tashiro, J.-i. Miyazaki, and Y. Seino
Proceedings of the National Academy of Sciences
(1999)
96 :14843
-
Preliminary report Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7–36)NH2,
amylin, cholecystokinin, and other possible regulators of nutrient uptake
A.A. Young, B.R. Gedulin, and T.J. Rink
Metabolism
(1996)
45 :1
-
Orlistat Augments Postprandial Increases in Glucagon-like Peptide 1 in Obese Type 2 Diabetic Patients
T. Damci, S. Yalin, H. Balci, Z. Osar, U. Korugan, M. Ozyazar, and H. Ilkova
Diabetes Care
(2004)
27 :1077
-
Ezetimibe Stimulates Intestinal Glucagon-Like Peptide 1 Secretion Via the MEK/ERK Pathway Rather Than Dipeptidyl Peptidase
4 Inhibition
Eugene Chang, Lisa Kim, Jung Mook Choi, Se Eun Park, Eun-Jung Rhee, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Dong Il Park,
and Cheol-Young Park
Metabolism
(2015)
64 :633
-
Glucagon-Like Peptide-1 7-36 Amide and Peptide YY Have Additive Inhibitory Effect on Gastric Acid Secretion in Man
A. Wettergren, P. Maina, S. Boesby, and J. J. Holst
Scandinavian Journal of Gastroenterology
(1997)
32 :552
-
Increased secretion of insulin and proliferation of islet β-cells in rats with mesenteric lymph duct ligation
Ko Nagino, Junji Yokozawa, Yu Sasaki, Akiko Matsuda, Hiroaki Takeda, and Sumio Kawata
Biochemical and Biophysical Research Communications
(2012)
425 :266
-
Glucagon-like Peptide-1 Plasmid Construction and Delivery for the Treatment of Type 2 Diabetes
Suna Choi, Seungjoon Oh, Minhyung Lee, and Sung Wan Kim
Molecular Therapy
(2005)
12 :885
-
Expression and purification of exendin-4, a GLP-1 receptor agonist, in Escherichia coli
Xiaopu Yin, Dongzhi Wei, Lina Yi, Xinyi Tao, and Yushu Ma
Protein Expression and Purification
(2005)
41 :259
-
The value of short- and long-acting glucagon-like peptide-1 agonists in the management of type 2 diabetes mellitus: experience
with exenatide
Xiao-Hui Guo
Current Medical Research and Opinion
(2016)
32 :61
-
Effects of the novel (Pro3)GIP antagonist and exendin(9–39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin
secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin
V. A. Gault, F. P. M. O'Harte, P. Harriott, M. H. Mooney, B. D. Green, and P. R. Flatt
Diabetologia
(2003)
46 :222
-
The effects of cereal source and processing on the metabolic responses to commercially available breakfast cereals and breads
R. M. Elliott, L. M. Morgan, J. A. Tredger, and J. Wright
International Journal of Food Sciences and Nutrition
(1994)
45 :217
-
Bile Acid Sequestration Reduces Plasma Glucose Levels in db/db Mice by Increasing Its Metabolic Clearance Rate
Maxi Meissner, Hilde Herrema, Theo H. van Dijk, Albert Gerding, Rick Havinga, Theo Boer, Michael Müller, Dirk-Jan. Reijngoud,
Albert K. Groen, Folkert Kuipers, and Irina Agoulnik
PLoS ONE
(2011)
6 :e24564
-
Changes in Gastrointestinal Hormone Responses, Insulin Sensitivity, and Beta-Cell Function Within 2 Weeks After Gastric Bypass
in Non-diabetic Subjects
S. H. Jacobsen, S. C. Olesen, C. Dirksen, N. B. Jørgensen, K. N. Bojsen-Møller, U. Kielgast, D. Worm, T. Almdal, L. S. Naver,
L. E. Hvolris, J. F. Rehfeld, B. S. Wulff, T. R. Clausen, D. L. Hansen, J. J. Holst, and S. Madsbad
Obesity Surgery
(2012)
22 :1084
-
Gastrointestinal satiety signals in humans — Physiologic roles for GLP-1 and PYY ?
Christoph Beglinger and Lukas Degen
Physiology & Behavior
(2006)
89 :460
-
Diurnal rhythms of plasma GLP-1 levels in normal and overweight/obese subjects: lack of effect of weight loss
Joaquín Santiago Galindo Muñoz, Diana Jiménez Rodríguez, and Juan José Hernández Morante
Journal of Physiology and Biochemistry
(2015)
71 :17
-
Plasticity of gastro-intestinal vagal afferent endings
Stephen J. Kentish and Amanda J. Page
Physiology & Behavior
(2014)
136 :170
-
Feeding an Elemental Diet vs a Milk-Based Formula Does Not Decrease Intestinal Mucosal Growth in Infant Pigs
Barbara Stoll, Pamela T. Price, Peter J. Reeds, Xiaoyan Chang, Josef F. Henry, Johannes B. van Goudoever, Jens J. Holst, and
Douglas G. Burrin
Journal of Parenteral and Enteral Nutrition
(2006)
30 :32
-
The endocrine disrupting potential of monosodium glutamate (MSG) on secretion of the glucagon-like peptide-1 (GLP-1) gut hormone
and GLP-1 receptor interaction
Maeve Shannon, Brian Green, Gary Willars, Jodie Wilson, Natalie Matthews, Joanna Lamb, Anna Gillespie, and Lisa Connolly
Toxicology Letters
(2017)
265 :97
-
Glucose sensing and signalling; regulation of intestinal glucose transport
S. P. Shirazi-Beechey, A. W. Moran, D. J. Batchelor, K. Daly, and M. Al-Rammahi
Proceedings of the Nutrition Society
(2011)
70 :185
-
Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes
M. Hiroyoshi, K. Tateishi, Y. Yasunami, K. Maeshiro, J. Ono, Y. Matsuoka, and S. Ikeda
The American Journal of Gastroenterology
(1999)
94 :976
-
The Inhibitory Effect of Glucagon-Like Peptide-1 (7-36)amide on Antral Motility is Antagonized by Its N-Terminally Truncated
Primary Metabolite GLP-1 (9-36)amide
A. Wettergren, M. Wøjdemann, and J.J. Holst
Peptides
(1998)
19 :877
-
Mechanisms and effects of “fat taste” in humans
Robin M. Tucker, Richard D. Mattes, and Cordelia A. Running
BioFactors
(2014)
40 :313
-
Adenoviral vector-mediated glucagon-like peptide 1 gene therapy improves glucose homeostasis in Zucker diabetic fatty rats
Yongho Lee, Mi Kyong Kwon, Eun Seok Kang, Young Mi Park, Seung Ho Choi, Chul Woo Ahn, Kyung Sub Kim, Chul Won Park, Bong Soo
Cha, Sung Wan Kim, Je Kyung Sung, Eun Jig Lee, and Hyun Chul Lee
The Journal of Gene Medicine
(2008)
10 :260
-
Evidence for the Gut Microbiota Short-Chain Fatty Acids as Key Pathophysiological Molecules Improving Diabetes
Alessandra Puddu, Roberta Sanguineti, Fabrizio Montecucco, and Giorgio Luciano Viviani
Mediators of Inflammation
(2014)
2014 :1
-
Nutrients related to GLP1 secretory responses
Asieh Mansour, Saeed Hosseini, Bagher Larijani, Mohamad Pajouhi, and Mohammad Reza Mohajeri-Tehrani
Nutrition
(2013)
29 :813
-
MECHANISMS IN ENDOCRINOLOGY: Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion
D. P. Sonne, M. Hansen, and F. K. Knop
European Journal of Endocrinology
(2014)
171 :R47
-
A Novel Glucose-Sensing Mechanism Contributing to Glucagon-Like Peptide-1 Secretion From the GLUTag Cell Line
F. M. Gribble, L. Williams, A. K. Simpson, and F. Reimann
Diabetes
(2003)
52 :1147
-
Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin
in isolated perfused porcine ileum
Lene Hansen, Bolette Hartmann, Hitoshi Mineo, and Jens J. Holst
Regulatory Peptides
(2004)
118 :11
-
Lack of Effects of a Single High-Fat Meal Enriched with Vegetable n-3 or a Combination of Vegetable and Marine n-3 Fatty Acids
on Intestinal Peptide Release and Adipokines in Healthy Female Subjects
Ingunn Narverud, Mari C. W. Myhrstad, Karl-Heinz Herzig, Toni Karhu, Tuva B. Dahl, Bente Halvorsen, Stine M. Ulven, and Kirsten
B. Holven
Frontiers in Nutrition
(2016)
3 :
-
Structural requirements of the N-terminal region of GLP-1-[7-37]-NH2 for receptor interaction and cAMP production
Cyril Sarrauste de Menthière, Alain Chavanieu, Gérard Grassy, Stéphane Dalle, Guillermo Salazar, Alain Kervran, Bruno Pfeiffer,
Pierre Renard, Philippe Delagrange, Dominique Manechez, David Bakes, Alain Ktorza, and Bernard Calas
European Journal of Medicinal Chemistry
(2004)
39 :473
-
Impact of early versus late enteral nutrition on cell mediated immunity and its relationship with glucagon like peptide-1
in intensive care unit patients: a prospective study
Okan Bakiner, Emre Bozkirli, Semih Giray, Zulfikar Arlier, Ilknur Kozanoglu, Nurzen Sezgin, Cagla Sariturk, and Eda Ertorer
Critical Care
(2013)
17 :R123
-
Enhancing Incretin Action for the Treatment of Type 2 Diabetes
D. J. Drucker
Diabetes Care
(2003)
26 :2929
-
Incretin hormone receptors are required for normal beta cell development and function in female mice
Bilal Omar, Linda Ahlkvist, Yuchiro Yamada, Yutaka Seino, and Bo Ahrén
Peptides
(2016)
79 :58
-
Signaling Mechanisms Underlying the Release of Glucagon-Like Peptide 1
F. Reimann, P. S. Ward, and F. M. Gribble
Diabetes
(2006)
55 :S78
-
Modulating GPR40: therapeutic promise and potential in diabetes
Vincent Poitout and Daniel C.-H. Lin
Drug Discovery Today
(2013)
18 :1301
-
Inhibition of human gastric lipase by intraduodenal fat involves glucagon-like peptide-1 and cholecystokinin
Morten Wøjdemann, Claus Riber, Thue Bisgaard, Berit Sternby, Steen Larsen, Jens F Rehfeld, Jens J Holst, and Ole Olsen
Regulatory Peptides
(1999)
80 :101
-
Insulin-Producing Intestinal K Cells Protect Nonobese Diabetic Mice From Autoimmune Diabetes
Majid Mojibian, Ada W.Y. Lam, Yukihiro Fujita, Ali Asadi, Guntram A. Grassl, Peter Dickie, Rusung Tan, Anthony T. Cheung,
and Timothy J. Kieffer
Gastroenterology
(2014)
147 :162
-
Effect of hormone therapy on the enteroinsular axis
Krystyna Sztefko, Iwona Rogatko, Tomasz Milewicz, Józef Krzysiek, Przemyslaw J Tomasik, and Zdzislaw Szafran
Menopause
(2005)
12 :630
-
Effects of intracerebroventricularly injected glucagon-like peptide-1 on cardiovascular parameters; role of central cholinergic
system and vasopressin
Naciye Isbil-Buyukcoskun and Guldal Gulec
Regulatory Peptides
(2004)
118 :33
-
Influences of protein ingestion on glucagon-like peptide (GLP)-1-immunoreactive endocrine cells in the chicken ileum
Mohammad M. Monir, Kohzy Hiramatsu, Sachiko Matsumoto, Kei Nishimura, Chihiro Takemoto, Tomomi Shioji, Takafumi Watanabe,
Kazumi Kita, Shinichi Yonekura, and Sang Gun Roh
Animal Science Journal
(2014)
85 :581
-
An Emerging Role of Glucagon-Like Peptide-1 in Preventing Advanced-Glycation-End-Product-Mediated Damages in Diabetes
Alessandra Puddu, François Mach, Alessio Nencioni, Giorgio Luciano Viviani, and Fabrizio Montecucco
Mediators of Inflammation
(2013)
2013 :1
-
Enhanced glucose‐dependent glucagon‐like peptide‐1 and insulin secretion in Crohn patients with terminal ileum disease is
unrelated to disease activity or ileal resection
N. Bendet, E. Scapa, O. Cohen, O. Bloch, D. Aharoni, Y. Ramot, M. Weiss, A. Halevi, and M. J. Rapoport
Scandinavian Journal of Gastroenterology
(2004)
39 :650
-
Incretin Mimetics as Emerging Treatments for Type 2 Diabetes
Scott V Joy, Philip T Rodgers, and Ann C Scates
Annals of Pharmacotherapy
(2005)
39 :110
-
The Influence of Restricted Feeding on Glucagon-Like Peptide-1 (GLP-1)-Containing Cells in the Chicken Small Intestine
M. M. Monir, K. Hiramatsu, A. Yamasaki, K. Nishimura, and T. Watanabe
Anatomia, Histologia, Embryologia
(2014)
43 :153
-
Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients
with inadequately controlled Type 2 diabetes
T. Forst, B. Uhlig-Laske, A. Ring, U. Graefe-Mody, C. Friedrich, K. Herbach, H.-J. Woerle, and K. A. Dugi
Diabetic Medicine
(2010)
27 :1409
-
Incretin-based therapies: mimetics versus protease inhibitors
Patricia L. Brubaker
Trends in Endocrinology & Metabolism
(2007)
18 :240
-
Glucagon-like peptide-1: The missing link in the metabolic clock?
Patricia L Brubaker and Manuel Gil-Lozano
Journal of Diabetes Investigation
(2016)
7 :70
-
Pharmacology and physiology of gastrointestinal enteroendocrine cells
O. J. Mace, B. Tehan, and F. Marshall
Pharmacology Research & Perspectives
(2015)
3 :e00155
-
Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus
Jens Juul Holst and Maria A. McGill
Clinical Drug Investigation
(2012)
32 :1
-
Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential
S. S. Torekov, S. Madsbad, and J. J. Holst
Obesity Reviews
(2011)
12 :593
-
Appetite control after weight loss: what is the role of bloodborne peptides?
Éric Doucet and Jameason Cameron
Applied Physiology, Nutrition, and Metabolism
(2007)
32 :523
-
The Effect of Nopal (Opuntia Ficus Indica) on Postprandial Blood Glucose, Incretins, and Antioxidant Activity in Mexican Patients
with Type 2 Diabetes after Consumption of Two Different Composition Breakfasts
Patricia López-Romero, Edgar Pichardo-Ontiveros, Azalia Avila-Nava, Natalia Vázquez-Manjarrez, Armando R. Tovar, José Pedraza-Chaverri,
and Nimbe Torres
Journal of the Academy of Nutrition and Dietetics
(2014)
114 :1811
-
Xenin, a Gastrointestinal Peptide, Regulates Feeding Independent of the Melanocortin Signaling Pathway
A. Leckstrom, E. R. Kim, D. Wong, and T. M. Mizuno
Diabetes
(2009)
58 :87
-
Metabolic impact of a successful lifestyle intervention in patients with new onset type 2 diabetes; a pilot study
Joe Begley, Antia Bowes, Tanya Hart, Soha Zouwail, and David Kerr
Journal of Diabetes Research and Clinical Metabolism
(2013)
2 :10
-
Probing the diurnal regulation of glycemic control
Shelagh M. Hampton and Jonathan D. Johnston
Journal of Diabetes and its Complications
(2014)
28 :751
-
Colestimide Lowers Plasma Glucose Levels and Increases Plasma Glucagon-like Peptide-1 (7-36) Levels in Patients with Type
2 Diabetes Mellitus Complicated by Hypercholesterolemia
Tatsuya Suzuki, Kenzo Oba, Yoshimasa Igari, Noriaki Matsumura, Kentaro Watanabe, Shoko Futami-Suda, Hiroko Yasuoka, Motoshi
Ouchi, Kazunari Suzuki, Yoshiaki Kigawa, and Hiroshi Nakano
Journal of Nippon Medical School
(2007)
74 :338
-
Evaluation of glycated glucagon-like peptide-1(7-36)amide in intestinal tissue of normal and diabetic animal models
Mark H Mooney, Yasser H.A Abdel-Wahab, Aine M McKillop, Finbarr P.M O’Harte, and Peter R Flatt
Biochimica et Biophysica Acta (BBA) - General Subjects
(2002)
1569 :75
-
GLP-1. Generalidades e interacción incretinas-nutrientes
M. de La Higuera López-Frías, S. Valdés Hernández, and F. Soriguer Escofet
Revista Clínica Española
(2007)
207 :501
-
Molecular mechanisms underlying nutrient-stimulated incretin secretion
Helen E. Parker, Frank Reimann, and Fiona M. Gribble
Expert Reviews in Molecular Medicine
(2010)
12 :
-
Systems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor System
Jonathan Janssens, Harmonie Etienne, Sherif Idriss, Abdelkrim Azmi, Bronwen Martin, and Stuart Maudsley
Frontiers in Endocrinology
(2014)
5 :
-
Incretin hormones and beta-cell mass expansion: what we know and what is missing?
Federica Tortosa and Francesco Dotta
Archives of Physiology and Biochemistry
(2013)
119 :161
-
Identification of amidated forms of GLP-1 in rat tissues using a highly sensitive radioimmunoassay
Jozef van Delft, L.O Uttenthal, O.G Hermida, Tomás Fontela, and Margarita Ghiglione
Regulatory Peptides
(1997)
70 :191
-
Novel Molecules Regulating Energy Homeostasis: Physiology and Regulation by Macronutrient Intake and Weight Loss
Anna Gavrieli and Christos S. Mantzoros
Endocrinology and Metabolism
(2016)
31 :361
-
Free fatty acids administered into the colon promote the secretion of glucagon-like peptide-1 and insulin
Tetsuya Adachi, Toshiki Tanaka, Kazuhisa Takemoto, Taka-aki Koshimizu, Akira Hirasawa, and Gozoh Tsujimoto
Biochemical and Biophysical Research Communications
(2006)
340 :332
-
Effect of dietary macronutrients on postprandial incretin hormone release and satiety in obese and normal-weight women
Tomasz Wikarek, Jerzy Chudek, Aleksander Owczarek, and Magdalena Olszanecka-Glinianowicz
British Journal of Nutrition
(2014)
111 :236
-
Nutritional influences on gut hormone release
Gary Frost, Audrey E Brynes, Sandra Ellis, Joanne E Milton, Mohsen Nematy, and Elena Philippou
Current Opinion in Endocrinology & Diabetes
(2006)
13 :42
-
Peripheral Signals Mediate the Beneficial Effects of Gastric Surgery in Obesity
Silvia Barja-Fernández, Cintia Folgueira, Cecilia Castelao, Rosaura Leis, Felipe F. Casanueva, and Luisa M. Seoane
Gastroenterology Research and Practice
(2015)
2015 :1
-
A novel long-acting glucose-dependent insulinotropic peptide analogue: enhanced efficacy in normal and diabetic rodents
K. Tatarkiewicz, D. M. Hargrove, C. M. Jodka, B. R. Gedulin, P. A. Smith, J. A. Hoyt, A. Lwin, L. Collins, L. Mamedova, O.
E. Levy, L. D'Souza, S. Janssen, V. Srivastava, S. S. Ghosh, and D. G. Parkes
Diabetes, Obesity and Metabolism
(2014)
16 :75
-
Targeting the TGR5-GLP-1 pathway to combat type 2 diabetes and non-alcoholic fatty liver disease
T.W. H. Pols, J. Auwerx, and K. Schoonjans
Gastroentérologie Clinique et Biologique
(2010)
34 :270
-
GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with
irritable bowel syndrome
p. m. hellström, e. näslund, t. edholm, p. t. schmidt, j. kristensen, e. theodorsson, j. j. holst, and s. efendic
Neurogastroenterology & Motility
(2008)
20 :649
-
Responses in gut hormones and hunger to diets with either high protein or a mixture of protein plus free amino acids supplied
under weight-loss conditions
Gerald E. Lobley, Grietje Holtrop, Graham W. Horgan, David M. Bremner, Claire Fyfe, and Alexandra M. Johnstone
British Journal of Nutrition
(2015)
113 :1254
-
Gut peptides and the regulation of appetite
M. S. B. Huda, J. P. H. Wilding, and J. H. Pinkney
Obesity Reviews
(2006)
7 :163
-
Individually timing high-protein preloads has no effect on daily energy intake, peptide YY and glucagon-like peptide-1
S M Willbond and É Doucet
European Journal of Clinical Nutrition
(2011)
65 :55
-
Impact of postprandial glycaemia on health and prevention of disease
E. E. Blaak, J.-M. Antoine, D. Benton, I. Björck, L. Bozzetto, F. Brouns, M. Diamant, L. Dye, T. Hulshof, J. J. Holst, D.
J. Lamport, M. Laville, C. L. Lawton, A. Meheust, A. Nilson, S. Normand, A. A. Rivellese, S. Theis, S. S. Torekov, and S.
Vinoy
Obesity Reviews
(2012)
13 :923
-
Glucagon-like peptides 1 and 2
Hannelouise Kissow
Current Opinion in Supportive and Palliative Care
(2015)
9 :196
-
Increased plasma levels of glucose-dependent insulinotropic polypeptide are associated with decreased postprandial energy
expenditure after modern Japanese meals
Noriko Osaki, Chika Suzukamo, Kouji Onizawa, Tadashi Hase, and Akira Shimotoyodome
European Journal of Nutrition
(2016)
:
-
Enteral supplementation with glutamine, fiber, and oligosaccharide modulates incretin and glucagon-like peptide-2 secretion
Erina Joo, Atsushi Muraoka, Akihiro Hamasaki, Norio Harada, Shunsuke Yamane, Yaeko Kondo, Kazuyo Suzuki, Daniela Nasteska,
Kimitaka Shibue, Takanari Harada, Kanako Iwasaki, Hidemi Tsuji, Kenichiro Shide, and Nobuya Inagaki
Journal of Diabetes Investigation
(2015)
6 :302
-
Insulin secretion in healthy subjects and patients with Type 2 diabetes – role of the gastrointestinal tract
Jing Ma, Christopher K. Rayner, Karen L. Jones, and Michael Horowitz
Best Practice & Research Clinical Endocrinology & Metabolism
(2009)
23 :413
-
Targeting postprandial hyperglycemia
Marc S. Rendell and Lois Jovanovic
Metabolism
(2006)
55 :1263
-
Nutritional regulation of glucagon-like peptide-1 secretion
Gwen Tolhurst, Frank Reimann, and Fiona M. Gribble
The Journal of Physiology
(2009)
587 :27
-
Glucose-dependent insulinotropic polypeptide (GIP) and the enteroinsular axis in equines (Equus caballus)
R Dühlmeier, E Deegen, H Fuhrmann, A Widdel, and H.-P Sallmann
Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology
(2001)
129 :563
-
Update on incretin hormones
Liza K. Phillips and Johannes B. Prins
Annals of the New York Academy of Sciences
(2011)
1243 :E55
-
GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice
Tanya Hansotia and Daniel J. Drucker
Regulatory Peptides
(2005)
128 :125
-
Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity
Giuseppina Opinto, Annalisa Natalicchio, and Piero Marchetti
Archives of Physiology and Biochemistry
(2013)
119 :170
-
Glucagon-like peptide 2: an update
Eric D Shin, Daniel J Drucker, and Patricia L Brubaker
Current Opinion in Endocrinology & Diabetes
(2005)
12 :63
-
GIF biology and fat metabolism
Rupert G.C. Yip and M.Michael Wolfe
Life Sciences
(1999)
66 :91
-
The role of food intake regulating peptides in cardiovascular regulation
B. Mikulášková, L. Maletínská, J. Zicha, and J. Kuneš
Molecular and Cellular Endocrinology
(2016)
436 :78
-
Free fatty acid receptor 2 and nutrient sensing: a proposed role for fibre, fermentable carbohydrates and short-chain fatty
acids in appetite regulation
Michelle L. Sleeth, Emily L. Thompson, Heather E. Ford, Sagen E. K. Zac-Varghese, and Gary Frost
Nutrition Research Reviews
(2010)
23 :135
-
A novel GLP-1 analog, BPI3006, with potent DPP IV resistance and good glucoregulatory effect
Caina Li, Yi Huan, Ning Shen, Lixia Ji, Sujuan Sun, Shuainan Liu, Quan Liu, Lihui Gao, Fenlai Tan, Yanping Wang, and Zhufang
Shen
Biochemical and Biophysical Research Communications
(2010)
400 :563
-
Pulmonary delivery of a GLP-1 receptor agonist, BMS-686117
Feng Qian, Neil Mathias, Paul Moench, Cecilia Chi, Sridhar Desikan, Munir Hussain, and Ronald L. Smith
International Journal of Pharmaceutics
(2009)
366 :218
-
Nutrient-induced secretion and metabolic effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1
J. M. E. Knapper, L. M. Morgan, and J. M. Fletcher
Proceedings of the Nutrition Society
(1996)
55 :291
-
Electrical activity-triggered glucagon-like peptide-1 secretion from primary murine L-cells
G. J. Rogers, G. Tolhurst, A. Ramzan, A. M. Habib, H. E. Parker, F. M. Gribble, and F. Reimann
The Journal of Physiology
(2011)
589 :1081
-
Association between coefficients of variation of the R-R intervals on electrocardiograms and post-challenge hyperglycemia
in patients with newly diagnosed type 2 diabetes
Yusuke Nakade, Toshinari Takamura, Masaru Sakurai, Hirofumi Misu, Mitsuko Nagata, Yuko Nanbu, Hiroyasu Oe, Toshiji Takamura,
Yoshio Sakai, Shuichi Kaneko, and Takashi Wada
Journal of Diabetes Investigation
(2011)
2 :324
-
Glucagon-like peptide-1 protects the murine hippocampus against stressors via Akt and ERK1/2 signaling
Yuta Yoshino, Mitsue Ishisaka, Saori Tsujii, Masamitsu Shimazawa, and Hideaki Hara
Biochemical and Biophysical Research Communications
(2015)
458 :274
-
Energy intake and obesity: Ingestive frequency outweighs portion size
Richard Mattes
Physiology & Behavior
(2014)
134 :110
-
What do we know about the secretion and degradation of incretin hormones?
Carolyn F. Deacon
Regulatory Peptides
(2005)
128 :117
-
Integration of Satiety Signals by the Central Nervous System
Adam P. Chambers, Darleen A. Sandoval, and Randy J. Seeley
Current Biology
(2013)
23 :R379
-
Glucose transporters are expressed in taste receptor cells
Flavia Merigo, Donatella Benati, Mirko Cristofoletti, Francesco Osculati, and Andrea Sbarbati
Journal of Anatomy
(2011)
219 :243
-
Effects of glucose-dependent insulinotropic polypeptide on glucagon
Mikkel Christensen and Filip K. Knop
Cardiovascular Endocrinology
(2016)
5 :75
-
Acute Effect on Satiety, Resting Energy Expenditure, Respiratory Quotient, Glucagon-Like Peptide-1, Free Fatty Acids, and
Glycerol Following Consumption of a Combination of Bioactive Food Ingredients in Overweight Subjects
Mariangela Rondanelli, Annalisa Opizzi, Simone Perna, Milena Faliva, Sebastiano Bruno Solerte, Marisa Fioravanti, Catherine
Klersy, Cava Edda, Paolini Maddalena, Scavone Luciano, Ceccarelli Paola, Castellaneta Emanuela, Savina Claudia, and Lorenzo
Maria Donini
Journal of the American College of Nutrition
(2013)
32 :41
-
Dynamics of insulin secretion and the clinical implications for obesity and diabetes
Susumu Seino, Tadao Shibasaki, and Kohtaro Minami
Journal of Clinical Investigation
(2011)
121 :2118
-
The effect of ileal interposition surgery on enteroendocrine cell numbers in the UC Davis type 2 diabetes mellitus rat
Carl Frederik Hansen, Efstathios Vassiliadis, Niels Vrang, Per T. Sangild, Bethany P. Cummings, Peter Havel, and Jacob Jelsing
Regulatory Peptides
(2014)
189 :31
-
Gut hormones as pharmaceuticals
Jens Juul Holst
Regulatory Peptides
(2000)
93 :45
-
Glucagon-Like Peptide-1 Gene Therapy
Anne M. Rowzee, Niamh X. Cawley, John A. Chiorini, and Giovanni Di Pasquale
Experimental Diabetes Research
(2011)
2011 :1
-
Synthesis and secretion of glucagon-like peptide-1 by fetal rat intestinal cells in culture
T. H. Jackson Huang and Patricia L. Brubaker
Endocrine
(1995)
3 :499
-
Incretins: new targets for the prevention of diabetes and obesity
Karl J Neff and Carel W le Roux
Clinical Lipidology
(2013)
8 :109
-
Calcitonin gene-related peptide potently stimulates glucagon-like peptide-1 release in the isolated perfused rat ileum
C Herrmann–Rinke, G.P McGregor, and B Göke
Peptides
(2000)
21 :431
-
Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects
R.J Bollag, Q Zhong, K.H Ding, P Phillips, L Zhong, F Qin, J Cranford, A.L Mulloy, R Cameron, and C.M Isales
Molecular and Cellular Endocrinology
(2001)
177 :35
-
Characterization of the Cellular and Metabolic Effects of a Novel Enzyme-Resistant Antagonist of Glucose-Dependent Insulinotropic
Polypeptide
Victor A. Gault, Finbarr P.M. O'Harte, Patrick Harriott, and Peter R. Flatt
Biochemical and Biophysical Research Communications
(2002)
290 :1420
-
Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic
control?
David J Grieve, Roslyn S Cassidy, and Brian D Green
British Journal of Pharmacology
(2009)
157 :1340
-
Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans
L.J. Karhunen, K.R. Juvonen, A. Huotari, A.K. Purhonen, and K.H. Herzig
Regulatory Peptides
(2008)
149 :70
-
Roles of cAMP signalling in insulin granule exocytosis
S. Seino, H. Takahashi, W. Fujimoto, and T. Shibasaki
Diabetes, Obesity and Metabolism
(2009)
11 :180
-
Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function
Chinmay S. Marathe, Christopher K. Rayner, Karen L. Jones, and Michael Horowitz
Experimental Diabetes Research
(2011)
2011 :1
